doxo-emch and Ovarian-Neoplasms

doxo-emch has been researched along with Ovarian-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for doxo-emch and Ovarian-Neoplasms

Article	Year
Combination therapy with the albumin-binding prodrug of doxorubicin (INNO-206) and doxorubicin achieves complete remissions and improves tolerability in an ovarian A2780 xenograft model. Investigational new drugs, 2012, Volume: 30, Issue:4 Topics: Albumins; Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Hydrazones; Mice; Mice, Nude; Ovarian Neoplasms; Prodrugs; Protein Binding; Remission Induction; Treatment Outcome; Xenograft Model Antitumor Assays	2012

Article

Year

Combination therapy with the albumin-binding prodrug of doxorubicin (INNO-206) and doxorubicin achieves complete remissions and improves tolerability in an ovarian A2780 xenograft model.

Investigational new drugs, 2012, Volume: 30, Issue:4

Topics: Albumins; Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Hydrazones; Mice; Mice, Nude; Ovarian Neoplasms; Prodrugs; Protein Binding; Remission Induction; Treatment Outcome; Xenograft Model Antitumor Assays

2012